Pfenex
10790 Roselle St
San Diego
California
92121
United States
Tel: 858-352-4400
Fax: 858-352-4602
Website: http://www.pfenex.com/
Email: croman@pfenex.com
109 articles about Pfenex
-
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option With Pfenex Inc. to Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
10/1/2013
-
Pfenex Inc. Strain Engineering to Host "Strategies for Accelerating Preclinical Development of Vaccines and Therapeutic Proteins" Seminar on Aug. 20th in Boston
6/19/2013
-
Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
4/30/2013
-
Pfenex Inc. and Agila Biotech Private Limited Announce Joint Venture to Develop Biosimilar Products for the Global Market
4/16/2013
-
Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Capacity Expansion for cGMP CRM197 Production
1/16/2013
-
Pfenex Inc. Welcomes Kristi Sarno as a Director of Business Development
12/5/2012
-
Pfenex Inc. Awards Althea Technologies, Inc. a Contract for cGMP Manufacturing of Circumsporozoite Protein From Plasmodium Falciparum, a Key Malaria Antigen
10/24/2012
-
Pfenex Inc. Awarded Contract by the National Institute of Allergy And Infectious Diseases (NIAID) (NIAID) to Develop an Alternative Delivery Method for its Recombinant Protective Antigen (rPA)-based Anthrax Vaccine
10/17/2012
-
Frost & Sullivan Lauds Pfenex Inc. for Developing a Protein Expression Platform that Delivers Unparalleled Success and Speed
6/5/2012
-
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option With Pfenex Inc. to Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
5/1/2012
-
Pfenex Inc. and DNA 2.0, Inc. Collaborate on Protein Expression Technology
3/1/2012
-
Pfenex Inc. and ProZyme, Inc. Establish Joint Collaboration and Supply Agreement
1/10/2012
-
Pfenex Inc. Reports Third-Quarter 2011 Results
11/1/2011
-
Pfenex Inc. Announces Strategic Agreement with SAFC
6/7/2011
-
Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Submission of Biologics Master File for Recombinant CRM197 to US FDA
5/17/2011
-
Pfenex Inc. Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology(TM)
5/10/2011
-
Pfenex Inc. and Boehringer Ingelheim Corporation Announce Non-Exclusive Strategic Agreement for the use of Pfenex Expression Technology(TM)
2/15/2011
-
Pfenex Inc. Awarded Sub-contract by Science Applications International Corporation (SAIC) to Help Develop a Scalable Production Process Based on Pfenex Expression Technology(TM) for a Key Malaria Antigen
1/26/2011
-
Pfenex Inc., Through its Reagent Proteins Business Division, Establishes Clinical Supply Agreement with Henry M. Jackson Foundation for the Advancement of Military Medicine
11/30/2010
-
Pfenex Inc. Through its Reagent Proteins Business Division, Establishes Clinical Supply Agreement With Henry M. Jackson Foundation
11/30/2010